Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma

Fig. 4

Patient survival in relation to TMB, PD-L1, or microsatellite status and genetic alterations. Kaplan-Meier plots of median (A) PFS and (B) OS of TMB high versus TMB low patients. Median (C) PFS and (D) OS of PD-L1 positive versus PD-L1 negative patients. Median (E) PFS and (F) OS of MSI versus MSS patients. MSI, microsatellite instability; MSS, microsatellite stability; PD-L1, programmed death-ligand 1; TMB, tumor mutational burden

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us